Search

Search Results

• Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia

  Francesco Marchesi, Fabrizio Ensoli, Irene Terrenato, Elena Papa, Fulvia Pimpinelli, Grazia Prignano, Antonio Spadea, Ilaria Cavallo, Enea Gino Di Domenico, Luigi Toma, Andrea Mengarelli

  e2020065

  2020-09-07

  https://doi.org/10.4084/mjhid.2020.065

  7758

  PDF: 696

  HTML: 195

• CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children

  Giuseppe Lassandro, Valentina  Palladino, Anna Amoruso, Viviana Palmieri, Giovanna Russo, Paola Giordano

  e2020042

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.042

  1351

  PDF: 901

  HTML: 291

• TYROSINE KINASE INHIBITORS AND PREGNANCY

  Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti

  e2014028

  2014-04-07

  https://doi.org/10.4084/mjhid.2014.028

  3430

  PDF: 1579

  HTML: 2662

• High Tuberculosis density incidence rate in Matched Unrelated Allogeneic stem cell transplantation recipients in the state of São Paulo, Brazil

  Marcelo Nóbrega Litvoc, silvia F costa, Fabio Eudes Leal, Diogo Boldim Ferreira, Max Igor Banks Ferreira Lopes, Ligia Capuani, Vanderson Geraldo Rocha

  e2023037

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.037

  555

  PDF: 808

  Suppl. Files: 69

  HTML: 199

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  3772

  PDF: 1415

  HTML: 8487

• NEGATIVE IMPACT OF PROLONGED ANTIBIOTICS OR PERSISTENT DIARRHEA ON VITAMIN K1 LEVELS IN 2-24 WEEKS AGED EGYPTIAN INFANTS

  Mohsen Elalfy, Fatma S E Ebeid, Iman Elagouza, Fatma Ibrahim, Noura Hassan, Beshoy Botros

  e2018010

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.010

  4189

  PDF: 803

  HTML: 953

• LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT

  Fabian Herrera

  e2024039

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.039

  1249

  PDF: 981

  HTML: 108

• WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

  Michele Bibas, Shayna Sarosiek , Jorge Castillo

  e2025015

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.015

  2193

  PDF: 1917

  HTML: 182